Posts about:
As the cold weather rolls in, health experts in the United States are encouraging people to get flu shots. The influenza virus mimics many of the symptoms of COVID-19 and is problematic for multiple reasons:
More than 11 million people in Canada have been tested for COVID-19, and thousands more are tested each day. To maximize the accuracy of these results, significant care must be exercised while handling and transporting these samples.
At the moment, 40 different vaccines for COVID are under test and trial. While we haven’t reached an endpoint with any of them, we soon will. One vaccine being developed by the University of Oxford is looking very promising and is in advanced stages of its development.
Since we’re nearing the closure of these trials and might have a vaccine soon, it’s time we also begin worrying about other matters: such as where to store these vaccines once we have them?
What good is an advanced technology if you can’t use it? At the moment, we’re still pretty far from intelligent machines like those who can make their own calculated decisions. The most we ever got to was bots conversing in gibberish.
For now, humans will have to do with manual controls. And sometimes, calibrating those controls can be a real deal.
While we all know platelets as the component of blood that helps it develop clots upon wounds, there’s more to these biconvex discoid structures. When it comes to storing them, they must be isolated from blood and stored separately, with plasma. The time period of their storage is usually five days. Over time, they undergo a number of storage changes, which makes their storage much more demanding.
Large biomedical corporations can make do with larger, more energy-consuming freezers—but what about small-scale biomedical research labs or clinics? Where do you store your samples and drugs?
